Older adults with weak 24-hour rest-activity rhythms face roughly 2.5 times the risk of developing dementia compared with those whose internal clocks run strong, according to converging evidence from multiple large prospective cohorts. The finding, drawn from wrist-worn activity monitors tracking tens of thousands of participants over years of follow-up, points to a measurable biological signal that may flag cognitive vulnerability long before memory complaints begin. With data spanning a 72,242-person sample from the UK Biobank, the Rush Memory and Aging Project, and the Study of Osteoporotic Fractures, the pattern holds across sexes, geographies, and analytic methods, raising pointed questions about whether strengthening circadian rhythms could slow or prevent cognitive decline.
Why circadian rhythm strength matters for dementia prevention
The core metric at issue is relative amplitude, a ratio that captures the difference between a person’s most active and least active periods across a 24-hour cycle. A high relative amplitude means sharp peaks of daytime movement and deep troughs of nighttime rest. A low value means the daily pattern is flat, with less distinction between waking activity and sleep. Each standard-deviation decrease in that measure was associated with a 54 percent higher risk of incident dementia, according to an institutional summary of research led in part by Wendy Wang, PhD, MPH, which synthesized results from multiple cohorts using wrist actigraphy.
That gradient matters because it suggests the relationship between rhythm weakness and dementia is not binary. People do not simply have “good” or “bad” clocks. Instead, the data describe a dose-response pattern: the flatter the daily activity curve, the higher the probability of a later dementia diagnosis. The group with the weakest rhythms faced approximately 2.5 times the dementia risk of those with the strongest patterns, even after adjustments for sleep duration, cardiovascular health, and other confounders that might blur the association.
This raises a practical question that no published trial has yet answered. If a structured intervention, such as timed bright-light exposure, scheduled physical activity, or more consistent meal timing, could push a person’s relative amplitude upward by even a fraction of a standard deviation over several months, would that translate into meaningfully lower dementia incidence over subsequent years? Based on the observed dose-response gradient, researchers have suggested that a 15 to 20 percent reduction in medium-term incidence among people whose rhythms strengthen is a plausible hypothesis to test. No randomized controlled trial has reported results on that specific outcome, but the observational data supply a strong rationale for designing one.
Actigraphy data from three major cohorts
The evidence does not rest on a single dataset. In the UK, investigators used wrist-worn accelerometers to characterize circadian patterns in more than 70,000 middle-aged and older adults. The resulting UK Biobank analysis linked reduced relative amplitude with increased risk of incident all-cause dementia and several other brain disorders. That sample’s size and demographic breadth give it statistical power that smaller studies cannot match, and its prospective design, with activity monitoring preceding diagnosis, reduces the chance that early-stage dementia was simply causing poor sleep and irregular activity rather than the reverse.
Separately, a long-running Chicago-based cohort, the Rush Memory and Aging Project, followed community-dwelling older adults for up to roughly 15 years, measuring baseline circadian metrics including amplitude, timing of peak activity, interdaily stability, and intradaily variability. Because participants underwent detailed annual cognitive assessments and brain autopsy in many cases, the study could examine whether rhythm disruption recorded at enrollment predicted clinically diagnosed Alzheimer’s disease and pathologic changes that emerged a decade or more later. The findings showed that weaker and more fragmented rhythms were associated with a higher likelihood of developing dementia over time.
A third line of evidence comes from a large cohort of women aged 65 and older enrolled in the Study of Osteoporotic Fractures. In that project, actigraphy-based measures revealed that participants with lower circadian rhythm amplitude and delayed activity timing had higher odds of developing dementia or mild cognitive impairment during follow-up. Because this cohort focused exclusively on women and used different recruitment and analytic strategies, its results add demographic specificity and confirm that the association is not an artifact of one research group, device, or statistical pipeline.
Taken together, these three datasets use different recruitment strategies, different follow-up lengths, and different statistical models, yet they converge on the same conclusion: weaker daily rhythms predict worse cognitive outcomes, often years before clinical symptoms become obvious. That convergence strengthens the case that circadian health is a meaningful dimension of brain aging, not merely a side effect of other illnesses.
Gaps in the circadian–dementia evidence
Several questions remain open. The most consequential is causality. All three cohorts are observational. They can show that weak rhythms precede dementia diagnoses, but they cannot prove that the rhythm disruption caused the disease rather than reflecting early, undetectable neurodegeneration that subtly alters sleep and activity patterns. The long follow-up in the Rush cohort, stretching to roughly 15 years in some participants, makes pure reverse causation less likely but does not rule it out entirely, especially for slowly developing neuropathology.
There is also a measurement transparency gap. The exact actigraphy algorithms and raw minute-level activity files used to derive relative amplitude in these cohorts have not been broadly released for independent teams to reanalyze. That limits full replication and makes it harder for clinicians to know whether a consumer-grade wrist tracker or smartphone-based sensor could produce comparable readings. For now, relative amplitude remains primarily a research tool rather than a standard clinical metric.
Another unresolved issue is how circadian rhythm strength compares with other sleep-related markers as a predictor of dementia. A separate analysis has reported that disturbed sleep itself may be more predictive of future cognitive decline than disrupted 24-hour activity rhythms in certain samples, suggesting that insomnia symptoms, sleep fragmentation, and sleep-disordered breathing might capture risk that circadian metrics only partially reflect. If that pattern holds across cohorts, clinicians may need to consider both nightly sleep quality and around-the-clock activity regularity when assessing brain health.
Confounding also remains a concern. People with weaker rhythms may differ systematically from those with stronger patterns in ways that are difficult to fully adjust for statistically. Lower physical activity, greater social isolation, depression, and chronic medical conditions can all flatten daily activity curves and independently increase dementia risk. While the large cohorts have adjusted for many of these factors, residual confounding is hard to eliminate, and it complicates efforts to translate observational hazard ratios into concrete prevention targets.
From association to intervention
Despite those caveats, the emerging picture has important implications for public health and clinical practice. At a minimum, actigraphy-based circadian metrics appear to flag individuals whose brains may be more vulnerable to aging-related decline. For researchers, that opens the door to using rhythm strength as an enrichment tool in prevention trials: enrolling participants with weak rhythms could increase the event rate and reduce the sample size needed to detect a protective effect of lifestyle or pharmacologic interventions.
For clinicians, the findings suggest that questions about daily routine and sleep–wake patterns may deserve more attention in midlife and early older age, not only as quality-of-life issues but as potential markers of long-term brain health. Encouraging regular bedtimes, consistent wake times, daytime light exposure, and structured daytime activity is already standard advice for improving sleep; these new data raise the possibility that such guidance might also influence dementia risk, even if the magnitude of that effect is still uncertain.
Ultimately, only randomized trials can determine whether deliberately strengthening circadian rhythms will reduce dementia incidence. Designing those trials will require practical decisions: which interventions are feasible at scale, how much change in relative amplitude is realistically achievable, and over what timeframe cognitive benefits, if any, might emerge. Until those answers arrive, the observational evidence from three major cohorts offers a clear message: in the aging brain, a robust daily rhythm is more than a lifestyle preference-it may be an early sign of resilience against dementia.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
